BAIJIN LIFE SCI (01466) announced that its indirect wholly-owned subsidiary, Beijing Baijin Biotechnology Co., Ltd. (Beijing Baijin), has entered into a strategic cooperation framework agreement with Shanghai Guhuan Medical Equipment Co., Ltd. (Guhuan Medical). Under the agreement, Beijing Baijin will invest in Guhuan Medical through equity subscription, aiming to establish direct sales channels for the Group's branded medical products. Additionally, Mr. Liang Liang is expected to be appointed as the Director of the Group's Medical Business Division, responsible for medical product expansion.

The cooperation framework agreement will expire on December 31, 2026, and either party may terminate it with 10 days' prior notice.

Shanghai Guhuan Medical Equipment Co., Ltd. has over a decade of experience in the medical product supply chain, with strong partnerships across upstream and downstream suppliers, and holds direct or indirect stakes in more than 30 medical aesthetic institutions. Mr. Liang Liang brings extensive expertise in the medical aesthetics industry, covering supply chain management, medical institution operations, and investment management.

The Board believes that this agreement will support the Group in enhancing its medical product market ecosystem—from R&D to proprietary sales channels—while steadily expanding revenue streams.